- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diaper Rash
Total 580 results
-
89bio, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Erasme University HospitalFractyl Laboratories, Inc.Completed
-
Can-Fite BioPharmaCompletedNon-alcoholic Steatohepatitis (NASH)Israel
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
Stefania BasiliUniversity of Roma La SapienzaRecruitingNAFLD | NASH - Nonalcoholic SteatohepatitisItaly
-
Gannex Pharma Co., Ltd.WithdrawnNonalcoholic Steatohepatitis (NASH)
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Blade TherapeuticsCompletedNASH - Nonalcoholic Steatohepatitis | Chronic Liver DiseaseAustralia
-
Cairo UniversityElsahel teaching hospitalCompletedNAFLD | NASH - Nonalcoholic SteatohepatitisEgypt
-
University Hospital, GrenobleInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement...RecruitingHBV | NASH - Nonalcoholic SteatohepatitisFrance
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis (MASH) | Non-alcoholic Fatty Liver Disease (MASLD)India
-
Inventiva PharmaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
89bio, Inc.ProSciento, Inc.Completed
-
University of California, DavisCompletedNonalcoholic Steatohepatitis (NASH) | Non-Alcoholic Fatty Liver Disease (NAFLD)United States
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Canada, France, Italy, Germany, Puerto Rico, Spain, United Kingdom
-
Duke UniversityCompletedLiver Diseases | Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
AllerganTerminatedRash | Non-small-Cell Lung CancerUnited States
-
Julius ClinicalUMC Utrecht; Erasmus Medical Center; Sint Franciscus GasthuisNot yet recruitingObesity | Metabolic Syndrome | Type 2 Diabetes | NAFLD | Fibrosis, Liver | Arterial Hypertension | NASH | NASH With Fibrosis | Steatosis of Liver
-
Harokopio UniversityUniversity of AthensCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Greece
-
Galectin Therapeutics Inc.CompletedNon-Alcoholic Steatohepatitis (NASH)United States
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Methodist Health SystemWithdrawnNon-alcoholic Steatohepatitis (NASH)United States
-
National Institute of Diabetes and Digestive and...CompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States
-
Humanity and Health Research CentreRecruitingNon-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH)Hong Kong
-
Indiana UniversityEchosensCompletedAdvanced Chronic Liver Disease, NASHUnited States
-
AstraZenecaCompletedNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | NASH | Fatty Liver, NonalcoholicUnited States
-
University of Alabama at BirminghamAstraZenecaTerminatedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States
-
Noom Inc.Arizona Liver HealthCompletedFatty Liver | Weight Loss | NAFLD | NASHUnited States
-
Jeffrey BrowningNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHealthy | NASH (Non-Alcoholic Steatohepatitis) | NAFLD (Non-Alcoholic Fatty Liver Disease)United States
-
Columbia UniversityThorne Research Inc.WithdrawnNASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver Disease
-
Terns, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Seoul St. Mary's HospitalGlaxoSmithKlineTerminatedNASH (Non-alcoholic Steato-hepatitis)
-
Novo Nordisk A/SCompleted
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
Boston PharmaceuticalsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Gilead SciencesCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Canada
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
-
AstraZenecaRecruiting
-
University of AarhusCompletedNASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver DiseaseDenmark
-
BASF ASUnknownNASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Fatty LiverUnited States
-
AstraZenecaParexelCompletedNon-alcoholic Steatohepatitis (NASH)United States
-
Medical University of ViennaRecruitingBariatric Surgery Candidate | NASH - Nonalcoholic Steatohepatitis | Intestinal PermeabilityAustria
-
Axcella Health, IncRecruitingNon Alcoholic Steatohepatitis (NASH)United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
-
TaiwanJ Pharmaceuticals Co., LtdNot yet recruitingNonalcoholic Steatohepatitis (NASH) With Fibrosis